New York, NY — Madison Group has unveiled its comprehensive Q3 financial report, showcasing a groundbreaking 30% increase in R&D investments dedicated to sustainable biopharmaceuticals and eco-friendly packaging solutions. This marks a pivotal moment in our global operations strategy, transforming theoretical sustainability targets into actionable, data-driven outcomes.
Medison Group Announces Record Q3 Technological Investments-2
Related Stories
Medison to Showcase Innovative Medical Aesthetic Equipment at China International Beauty Expo 2026
Medison showcased its products at the 2023 Jiangxi Medical Device Exhibition, with three consumables, including scar gel, sparking a purchasing frenzy.
Medison showcased its innovative medical device solutions at the 2024 Asia International Medical Device & Laboratory Exhibition, attracting global buyers' attention.
Medison
Weihai Medison Medical Equipment Co., Ltd. has a professional R&D and manufacturing team composed of high-level experts. In the fields of vascular intervention, urology, gynecology, cosmetology, etc., it proposes new research ideas and targeted solutions based on the current technical status of small and medium-sized equipment, consumables, biological preparations, raw materials, etc.
Solutions
Company
- Our History
- Media Center
Product
Contact Us
Qujiahe Industrial Park , Yangting Town,Huancui District,Weihai City
Hotline：400 811 7709
Tel： +86-631-5337707
Fax：+86-631-5337706
E-mail：imedison01@imedison.com
© 2026 Medison Group Corporation. All Rights Reserved. | Site powered by Matchpages